Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Diagnostics Market, By Product
7.1. Veterinary Diagnostics Market, By Product, 2020-2030
7.1.1. Consumables, Reagents & Kits
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Instruments & Devices
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Veterinary Diagnostics Market, By Species
8.1. Veterinary Diagnostics Market, By Species, 2020-2030
8.1.1. Bovine
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Camelid
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Canine and Feline
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Caprine
8.1.4.1. Market Revenue and Forecast (2016-2030)
8.1.5. Equine
8.1.5.1. Market Revenue and Forecast (2016-2030)
8.1.6. Ovine
8.1.6.1. Market Revenue and Forecast (2016-2030)
8.1.7. Porcine
8.1.7.1. Market Revenue and Forecast (2016-2030)
8.1.8. Avian
8.1.8.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Veterinary Diagnostics Market, By Testing Category
9.1. Veterinary Diagnostics Market, By Testing Category, 2020-2030
9.1.1. Analytical Services
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Diagnostic Imaging
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Bacteriology
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Pathology
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Molecular Diagnostics
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Immunoassays
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Parasitology
9.1.7.1. Market Revenue and Forecast (2016-2030)
9.1.8. Serology
9.1.8.1. Market Revenue and Forecast (2016-2030)
9.1.9. Virology
9.1.9.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Veterinary Diagnostics Market, By Disease Type
10.1. Veterinary Diagnostics Market, By Disease Type, 2020-2030
10.1.1. Infectious Diseases
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Non-infectious Diseases
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Hereditary, Congenital, and Acquired Diseases
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. General Ailments
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Structural and Functional Diseases
10.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Veterinary Diagnostics Market, By End-Use
11.1. Veterinary Diagnostics Market, By End-Use, 2020-2030
11.1.1. Laboratories
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Veterinary Hospitals and Clinics
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. Point-Of-Care/In-House Testing
11.1.3.1. Market Revenue and Forecast (2016-2030)
11.1.4. Research Institutes and Universities
11.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Veterinary Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Product (2016-2030)
12.1.2. Market Revenue and Forecast, By Species (2016-2030)
12.1.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.1.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.1.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, By Product (2016-2030)
12.1.6.2. Market Revenue and Forecast, By Species (2016-2030)
12.1.6.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.1.6.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.1.6.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, By Product (2016-2030)
12.1.7.2. Market Revenue and Forecast, By Species (2016-2030)
12.1.7.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.1.7.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.1.7.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, By Product (2016-2030)
12.2.2. Market Revenue and Forecast, By Species (2016-2030)
12.2.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.2.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.2.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, By Product (2016-2030)
12.2.6.2. Market Revenue and Forecast, By Species (2016-2030)
12.2.6.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.2.6.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.2.6.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, By Product (2016-2030)
12.2.7.2. Market Revenue and Forecast, By Species (2016-2030)
12.2.7.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.2.7.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.2.7.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, By Product (2016-2030)
12.2.8.2. Market Revenue and Forecast, By Species (2016-2030)
12.2.8.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.2.8.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.2.8.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, By Product (2016-2030)
12.2.9.2. Market Revenue and Forecast, By Species (2016-2030)
12.2.9.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.2.9.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.2.9.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, By Product (2016-2030)
12.3.2. Market Revenue and Forecast, By Species (2016-2030)
12.3.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.3.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.3.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, By Product (2016-2030)
12.3.6.2. Market Revenue and Forecast, By Species (2016-2030)
12.3.6.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.3.6.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.3.6.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, By Product (2016-2030)
12.3.7.2. Market Revenue and Forecast, By Species (2016-2030)
12.3.7.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.3.7.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.3.7.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, By Product (2016-2030)
12.3.8.2. Market Revenue and Forecast, By Species (2016-2030)
12.3.8.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.3.8.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.3.8.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, By Product (2016-2030)
12.3.9.2. Market Revenue and Forecast, By Species (2016-2030)
12.3.9.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.3.9.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.3.9.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, By Product (2016-2030)
12.4.2. Market Revenue and Forecast, By Species (2016-2030)
12.4.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.4.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.4.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, By Product (2016-2030)
12.4.6.2. Market Revenue and Forecast, By Species (2016-2030)
12.4.6.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.4.6.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.4.6.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, By Product (2016-2030)
12.4.7.2. Market Revenue and Forecast, By Species (2016-2030)
12.4.7.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.4.7.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.4.7.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, By Product (2016-2030)
12.4.8.2. Market Revenue and Forecast, By Species (2016-2030)
12.4.8.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.4.8.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.4.8.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, By Product (2016-2030)
12.4.9.2. Market Revenue and Forecast, By Species (2016-2030)
12.4.9.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.4.9.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.4.9.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Product (2016-2030)
12.5.2. Market Revenue and Forecast, By Species (2016-2030)
12.5.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.5.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.5.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, By Product (2016-2030)
12.5.6.2. Market Revenue and Forecast, By Species (2016-2030)
12.5.6.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.5.6.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.5.6.5. Market Revenue and Forecast, By End-Use (2016-2030)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, By Product (2016-2030)
12.5.7.2. Market Revenue and Forecast, By Species (2016-2030)
12.5.7.3. Market Revenue and Forecast, By Testing Category (2016-2030)
12.5.7.4. Market Revenue and Forecast, By Disease Type (2016-2030)
12.5.7.5. Market Revenue and Forecast, By End-Use (2016-2030)
Chapter 13. Company Profiles
13.1. Abaxis, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Idexx Laboratories, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Heska Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Neogen Corp
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Merck
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Thermo Fisher Scientific, Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Qiagen N.V.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Virbac Corp
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Zoetis, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. IDVet
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Agrolabo SPA
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Im3 Inc.
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. VCA Antech
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
13.14. Henry Schein, Inc.
13.14.1. Company Overview
13.14.2. Product Offerings
13.14.3. Financial Performance
13.14.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms